The medical field is seeing a major shift in diabetes therapy with the emergence of GLP-1 transdermal devices. These revolutionary delivery systems offer a likely easy alternative to injections for individuals managing diabetes mellitus type 2. By circumventing the requirement for frequent injections, GLP-1 adhesives promise to improve patient comp